Joyce O'Shaughnessy, MD discusses the importance of IBC 2018

Benefit from the content at IBC 2018 West or EastПодробнее

Joyce O'Shaughnessy, MD discusses the importance of IBC 2018Подробнее

Dr. Joyce O’Shaughnessy on Promising Agents in Triple-Negative Breast CancerПодробнее

Dr. Joyce O'Shaughnessy invites you the International Congress on the Future of Breast CancerПодробнее

Joyce O’Shaughnessy, MD: Treatment Goals for Patients With TNBC and Multiple Metastatic SitesПодробнее

You're Invited to the 18th Annual International Congress on the Future of Breast Cancer®Подробнее

Inclusion of Breast Cancer Index in GuidelinesПодробнее

Joyce O'Shaughnessy, MD explains the importance of The School of Breast OncologyПодробнее

Joyce O'Shaughnessy, MD on the SOBO Mid-Year Update WebcastПодробнее

Joyce O’Shaughnessy, MD: Fourth-Line ConsiderationsПодробнее

Dr. O'Shaughnessy on Precision Medicine in Triple Negative Breast CancerПодробнее

What is inflammatory breast cancer? Patient Jennifer Cordts talks with Dr. Joyce O’ShaughnessyПодробнее

Joyce O’Shaughnessy, MD: Treatment Goals for Patients With TNBCПодробнее

Dr. O'Shaughnessy on Adding Phosphoprotein Testing to Genomic Testing for Breast CancerПодробнее

Joyce O’Shaughnessy, MD: Principle Third-Line Options for Patients With Metastatic TNBCПодробнее

Joyce O’Shaughnessy, MD: Third-Line Options to Prolong LifeПодробнее

Dr. O'Shaughnessy on Phosphoprotein Assays for Treatment Decision-Making for Breast CancerПодробнее

Dr. Joyce O'Shaughnessy Invites you to SOBO 2020 in Atlanta, GA November 5-7thПодробнее

Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast CancerПодробнее

Joyce O’Shaughnessy, MD: Different Mechanisms of Action in EribulinПодробнее